NASDAQ: NRSN
Neurosense Therapeutics Ltd Stock Ownership - Who owns Neurosense Therapeutics?

Insider buying vs selling

Have Neurosense Therapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NRSN insiders and whales buy or sell their stock.

NRSN Shareholders

What type of owners hold Neurosense Therapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC0.61%149,243$174.61kInstitution
Morgan Stanley0.32%79,900$93.48kInstitution
Squarepoint Ops LLC0.20%49,925$58.41kInstitution
Meitav Investment House Ltd 10.16%40,000$46.80kInstitution
Jane Street Group LLC0.12%28,689$33.57kInstitution
Hrt Financial LP0.09%21,694$25.38kInstitution
Commonwealth Equity Services LLC0.09%21,080$24.66kInstitution
Geode Capital Management LLC0.06%15,870$18.57kInstitution
Marshall Wace LLP0.05%11,828$13.84kInstitution
Jones Financial Companies LLLP0.04%10,919$12.78kInstitution

1 of 2

NRSN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRSN1.83%0.00%
CASI2.75%97.25%
TENX21.85%78.15%
RENB8.38%67.38%
ITRM5.30%51.07%Net BuyingNet Buying

Neurosense Therapeutics Stock Ownership FAQ

Who owns Neurosense Therapeutics?

Neurosense Therapeutics (NASDAQ: NRSN) is owned by 1.83% institutional shareholders, 0.00% Neurosense Therapeutics insiders, and 98.17% retail investors. Citadel Advisors LLC is the largest individual Neurosense Therapeutics shareholder, owning 149,243.00 shares representing 0.61% of the company. Citadel Advisors LLC's Neurosense Therapeutics shares are currently valued at $176.11k.

If you're new to stock investing, here's how to buy Neurosense Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.